S100A2 and atopic eczema: In addition, histological analysis of S100A2 and HMGB1 reflects the severity of drug eruption [62,111], however, they could not reflect the specificity of drug eruption, because they are increased in other inflammatory skin diseases, such as atopic dermatitis and psoriasis.